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The administration of a single bolus of anti-IgM antibody to foetal lambs early in pregnancy produces
prolonged B-cell depletion. The present study investigated this depletion by examining the effect,
on B-cell development in the ileal Peyer’s patches, of varying the timing and dosage of antibody
administration and by supplementing anti-IgM with surgical splenectomy. The capacity of a 1mg bolus
of anti-IgM to deplete Peyer’s patches of B cells was lost if its administration was deferred until two
thirds of the way through pregnancy, but persisted beyond this time if weight-adjusted doses were used.
Splenectomy of the foetus performed at an earlier age failed to extend the age at which a 1mg dose of
antibody remained effective. As the concentration of murine immunoglobulin in foetal serum was
greatly reduced after 21 days, it is inferred that ongoing suppression of B-cell development is not
dependent on the continued presence of murine immunoglobulin. The enduring nature of suppression
couldbe attributable to a limited period during which differentiation of B cells from stem cells normally
occurs, although further studies will be needed to investigatethis and other possible explanations for the
effect of anti-IgM treatment on prenatal B-cell development in sheep.
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INTRODUCTION
The demonstration that a single injection of an anti-IgM
monoclonal early in gestation depleted the B-cell
populations in foetal sheep raised a number of questions
as to the nature of prenatal B-cell development in sheep
(Press et al., 1996; 1998). In laboratory mammals such as
mice and rabbits, maintenance of the suppression of B-cell
development in the neonate requires repeated injections of
anti-IgM antibodies (Gordon, 1979; Cooper et al., 1980).
It has been shown that the modulation of the IgM receptor
of neonatal B cells by antibodies leads to aborted B-cell
development (Cooper et al., 1980) and studies in 8-week-
old lambs have also shown that ileal Peyer’s patch B cells
can be induced to undergo apoptosis or switch off
proliferation by surface immunoglobulin ligation (Griebel
et al., 1991; Motyka et al., 1995). The conclusion from an
initial series of experiments with B-cell depleted lambs
was that the administration of anti-IgM to foetal sheep at
63 days of gestation (dg; gestation in sheep is 150 days)
had inhibited cell division and/or induced cell death in
surface IgMþ cells (Press et al., 1996).
The requirement for repeated injections of anti-IgM
antibody to maintain B-cell depletion in mice arises
because on-going antigen independent differentiation of
stem cells to B cells occurs ﬁrst in the foetal liver and then
in the bone marrow of the adult (Alt et al., 1987). The rate
of production of pre-B cells does not differ between anti-
IgM-treated mice and controls given normal rabbit serum
indicating that these precursors are not susceptible to this
antibody (Opstelten and Osmond, 1985). In foetal sheep,
in contrast to the effects observed in mice, a single
injection of anti-IgM antibody at 63dg maintained a
marked depletion of surface IgMþ cells for 80 days. One
possible explanation for this long-standing effect of anti-
IgM treatment was that an IgMþ cell population crucial
for ongoing B-cell production was inactivated or
eliminated. The ileal Peyer’s patch is responsible for the
production of the vast majority of B cells in sheep and
active lymphopoiesis begins in this site at around 100dg
(Reynolds and Morris, 1983; Press et al., 1992). The
earliest IgMþ B cells have been detected in the foetal
spleen at 45–50dg (Maddox et al., 1987a; Press et al.,
1993). At 63dg, B cells are prominent in the spleen and it
was suggested that the removal of this population was
responsible for the marked depletion of B cells seen in
foetuses at around 140dg (Press et al., 1996). However,
a subsequent experiment in which surgical splenectomy
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the ﬁnding that the morphology of the lymphoid tissue of
operated foetuses was substantially normal when exam-
ined near term (Press et al., 2001). This clear-cut
demonstration of the non-equivalence of anti-IgM
administration and splenectomy was interpreted as
indicating that other, unidentiﬁed parts of the lymphoid
system could compensate for the loss of the spleen.
In contrast, it would appear that antibody administration
either inactivated an essential cell population and/or
exerted a continuing effect that was sufﬁcient to inactivate
potential replacement cells.
Reynaud et al. (1991) suggested that the limited pattern
of light chain rearrangement observed in the ileal Peyer’s
patch of sheep indicated that immunoglobulin gene
rearrangement only occurred during a narrow window of
development. The experiments with B-cell depleted sheep
have drawn attention to the nature of this window in
B-cell development. An important aspect of this
experimental model that was not addressed in the initial
series of experiments (Press et al., 1996; 1998), was the
duration of the effect of anti-IgM administration. The
catabolic rate of ovine gamma globulin experimentally
introduced in foetal ruminants is extremely low
(Fukumoto and Brandon, 1985). This has been attributed
to the agammaglobulinaemic status of these foetal
animals, on the basis of the linkage that exists between
catabolic rate at any time and the serum globulin level
(Fukumoto and Brandon, 1985). However, it has also been
demonstrated that sufﬁcient lysosomal enzyme activity
exists in the foetal liver, spleen, lymph nodes and plasma
to account for a signiﬁcant amount of protein degradation
(Fukumoto and Brandon, 1985). Thus, the kinetics of the
single bolus of injected murine antibody in foetal lambs
remain uncertain.
This paper reports experiments in which examination of
the consequences of variations in dosage and gestational
age at administration of anti-IgM, and of combining
splenectomy with an antibody administration regime was
undertaken. These experiments were performed to assist in
identifying the detailed mechanism of antibody action. The
interpretation of these observations was supplemented by
observation of the duration of persistence of administered
murine gamma globulin in the foetal lamb circulation.
MATERIALS AND METHODS
Animals and Tissue Collection
Foetal lambs of known gestational agewere obtained from
timed matings of Merino ewes. To achieve this,
intravaginal sponges containing ﬂugestone acetate
(40mg Chronogest, Laboratiore Pharmacetique, Porges,
France) were placed in the ewes to be mated. Eleven days
later, sponges were removed and ewes penned with rams
wearing a harness with an attached crayon that marked
each ewe at the time of joining. Pregnancy was conﬁrmed
by ultrasound examination of ewes 6 weeks after joining.
Surgery was undertaken to administer the murine
monoclonal antibody to foetal lambs and to perform
splenectomy.Ineachcase,theewewasfastedovernightand
anaesthesiawasinducedwiththiopentone,andaftertracheal
intubation, maintained with halothane (1–2%). After
laparotomy and exposure of the uterus, the myometrium
was incised using cautery allowing the foetal membranes to
protrude. Injection of antibody into the foetal peritoneal
cavity was performed under direct vision through the foetal
membranes. The needle was introduced into the amniotic
cavity through the intact myometrium to prevent leakage of
ﬂuid. The antibody used was the mouse monoclonal
antibody MCM 9 (Beh, 1988), puriﬁed by Protein G
chromatographyfromcellculturesupernatantandsterilized
by ﬁltration (0.22mm). Another IgG mouse antibody
directed against an epithelial component of the follicle-
associated epithelium (Du2-69; Landsverk T. and Hein,
W.R., personal communication) was also injected intra-
peritoneally and tissues collected used as a control.
Splenectomy was performed as previously described
(Press et al.,2 0 0 1 ) .
Necropsy was performed at the required gestational age
following induction of general anaesthesia and the ewe
and foetus were euthanased with individual overdose
injections of barbiturate. All animal procedures were
approved by the Australian National University Animal
Experimentation Ethics Committee in accord with
the Code of Practice for the Care and Use of Animals
for Scientiﬁc Purposes of the Australian National Health
and Medical Research Council. The collection of
frozen tissues from B-cell depleted foetal lambs and
splenectomised foetal lambs has been previously
described (Press et al., 1996; 2001). Blood was collected
from foetal lambs into plain blood collection tubes and
allowed to stand at 48C overnight. Serum was collected
and stored at 2708C until analysis.
Enzyme and Immunohistochemistry
The detection of reactivity for the enzyme 50nucleotidase
has been described previously (Halleraker et al., 1990).
An avidin-biotin-peroxidase immunohistochemical
technique was used to stain frozen tissue sections, using
a protocol that has been described previously (Gunnes
et al., 1999). The primary antibodies used in this
procedure were a rabbit polyclonal antibody directed
against sheep IgM (m-chain speciﬁc; Cappel Research
Products, Durham, NC, USA) and a mouse monoclonal
antibody directed against sheep complement receptor-2
(CD21, clone Du2-87-6 (Hein et al., 1998)).
Estimation of Murine Immunoglobulin in Foetal
Sheep Serum
A radial immunodiffusion assay as described previously
(Mancini et al., 1964) and a rabbit polyclonal antibody
(Dako, ID1797, Glostrup, Denmark) directed against
mouse IgG were used. The diameters of the precipitation
P. MCCULLAGH et al. 20zones were measured by using a “measuring viewer”
(Behringwerke) and micrograms mouse IgG in foetal
sheep serum were calculated from a standard curve
derived from ﬁve dilutions of puriﬁed mouse IgG (Dako,
ID1915) on each plate. Negative samples contained less
than 4mg mouse IgG per ml (,0.0043mg/ml).
RESULTS
Deﬁnition of Dose of Anti-IgM Antibody Sufﬁcient to
CurtailB-cellDevelopmentifadministeredto63Day-old
Foetal Lambs
As earlier experiments had been conﬁned to the use of a
single dose of anti-IgM antibody at a single age, it was not
possible to decide whether this dose was close to that
which is essential to produce the observed effect or
considerably in excess of it. As it was intended in the
present series of experiments to compare the effect of a
common dose of antibody administered to different foetal
lambs at a range of gestational ages, a dose-response
estimation was undertaken at the age previously
examined. The well-deﬁned appearance of cellular
depletion in the lymphoid nodules of the ileal Peyer’s
patch, which are normally populated by B cells, was used
as the basis for determining the outcome of a series of
decreasing doses of anti-IgM monoclonal antibody
(Table I). In the non-operated control animals, the ileal
Peyer’s patch between 135–142dg contains large
lymphoid nodules ﬁlled with IgMþ B cells (Fig. 1), as
did the ileal Peyer’s patch of control animals that received
an irrelevant mouse IgG antibody at 56dg (not shown).
The nodules also show extensive immunoreactivity for
CD21, which is present on B cells and follicular dendritic
cells, and enzyme reactivity for 50nucleotidase, which is
present in the extensive stromal cell network in the
nodules. In Fig. 1, the inﬂuence of anti-IgM antibody
administered intraperitoneally at 63dg on B-cell develop-
ment in the ileal Peyer’s patch is illustrated. Doses of 1.5
and 1.0mg resulted in depletion of IgMþ B cells from
nodules in the ileal Peyer’s patch, while doses of 0.5 and
0.25mg did not completely impede colonisation and
expansion of IgMþ B cells in Peyer’s patch nodules.
On the basis of these observations, a dose of 1mg was
given in all subsequent procedures, unless otherwise
indicated.
The Effects of a Single Dose of 1mg of Anti-IgM
Monoclonal Antibody on Foetal Lambs at a Range of
Gestational Ages
It would be anticipated that if the cell population that
was being inactivated by the administration of a single
inoculum of anti-IgM antibody at 63dg remained
susceptible and accessible thereafter, administration of
this antibody at subsequent stages of gestation should
exert a similar effect on B-cell development, provided that
the concentration of antibody achieved in the compart-
ments containing these cells was adequate. If the size of
the cell population to which the monoclonal antibody was
targeted exceeded the capacity of that antibody to
inactivate them, a gradual decrease in the efﬁciency with
which B-cell development was curtailed might have been
anticipated. On the other hand, if for other reasons such as
microanatomical inaccessibility or cell surface insuscepti-
bility to binding of the antibody, the target cells were
to become resistant to antibody-mediated inactivation,
a precipitate decline in the efﬁcacy of inactivation might
be observed. In Fig. 2, the effect on ileal Peyer’s patch
development of a single dose of 1mg anti-IgM antibody at
ages ranging from 70–105dg is presented.
The intraperitoneal administration of 1mg of anti-IgM
monoclonal antibody up until 84dg achieved a marked
depletion of B cells (Table II). The nodules in the ileal
Peyer’s patch of foetuses treated at 91dg, did not show
signs of depletion, while the three foetuses treated at 98dg
did show signs of depletion (Fig. 2). At 105dg, the treated
foetuses did not show signs of depletion.
Body Weight-adjusted Doses of Anti-IgM Monoclonal
Antibody extend the Gestational Age at which B-cell
Development could be Disrupted
The lack of effect of anti-IgM antibody on the
development of B cells in the ileal Peyer’s patch, which
was present when exposure was delayed until 105dg,
could reﬂect a decrease of antibody concentration in
the foetal extracellular compartment. To assess this
possibility, an antibody dose was administered at 98 and
105dg that had been appropriately adjusted to match the
weight of the foetal lamb for a standard 1mg dose at
63dg. A marked B-cell depletion of nodules in the ileal
Peyer’s patch after treatment with the weight-adjusted
doses (12.5mg at 98dg and 15mg at 105dg) was present
TABLE I Dose-response estimation of anti-IgM antibody (aIgM) on B-cell development at 63 days of gestation (dg)
Treatment Number of foetuses Age at operation (dg) Age at necropsy (dg) Effect on nodules
1.5mg aIgM 1 63 139 Depleted
1.0mg aIgM 2 63 139 Depleted
0.5mg aIgM 1 63 140 Irregular sizes
0.25mg aIgM 2 63 139 Irregular sizes
1.0mg mouse 4 56 140 Normal
IgG
Control 8 – 135–142 Normal
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Thus, an increase in the dose of anti-IgM antibody to
restore the dose/body weight ratio to that applying when
1mg was administered to 63dg foetal lambs impeded
B-cell development in the ileal Peyer’s patch.
Failure of Splenectomy at 56dg to restore the Capacity
of 1mg Anti-IgM Antibody administered at 105dg to
Deplete the Ileal Peyer’s Patch of B Cells
If the inability of anti-IgM antibody to perturb B-cell
development reﬂects an inadequacy of antibody concen-
tration in the appropriate tissue compartments, then
reducing the size of the B-cell compartment in foetal
lambs may restore the capacity of lower doses of anti-IgM
to impede B-cell development at later stages of gestation.
Alternatively, otherwise susceptible populations may be
sequestered in the spleen. To investigate these possibi-
lities, splenectomies were performed in combination with
the intraperitoneal administration of anti-IgM antibody.
Previous studies have shown that the spleen is a major site
of early B-cell accumulation (Press et al., 1993) and while
splenectomy at 56dg does not prevent B-cell development
in the ileal Peyer’s patch (Press et al., 2001), its removal
would be expected to eliminate an important micro-
environment for the expansion of the B-cell compartment
in foetal lambs.
Foetal lambs were splenectomised at 56dg and then
inoculated with 1mg anti-IgM antibody at 56dg or at
105–106dg (Table IV). At necropsy, the ileal Peyer’s
patch did not show a marked depletion of B cells when
foetal lambs were inoculated with anti-IgM antibody at
105–106dg in splenectomised animals, although two
individuals showed signs ofirregular nodular development
(Fig. 4).
FIGURE 1 B-cell development in the pre-natal ileal Peyer’s patch of
lambs following intraperitoneal administration of various doses of anti-
IgM antibody at 63 days of gestation (dg). Normal untreated control
lambs possess large nodules (n) that show staining (brown) for (A) CD21
and (B) ovine IgM. Following administration of 1.5mg anti-IgM
antibody, small rudimentary nodules (r) are present that show staining for
(C) CD21 but not for (D) ovine IgM. Following administration of 0.5mg
anti-IgM antibody, large nodules (n) are present that show staining for
(E) CD21 and (F) ovine IgM. Bar ¼ 50mm: Frozen sections.
FIGURE 2 B-cell development in the pre-natal ileal Peyer’s patch of
lambs following intraperitoneal administration of 1mg anti-IgM
antibody at a range of gestational ages (dg). Following administration
of anti-IgM antibody, immunohistochemical staining for CD21 (brown)
shows that: (A) At 70dg, small rudimentary nodules (r) are present.
Bar ¼ 50mm: (B) At 91dg, large nodules (n) are present. Bar ¼ 100mm:
(C) At 98dg, small rudimentary nodules (r) are present. Bar ¼ 50mm:
(D) At 105dg, large nodules (n) are present. Bar ¼ 100mm: Frozen
sections.
TABLE II Effect of anti-IgM antibody (aIgM) administered at 7-day intervals from 70 to 105 days of gestation on B-cell development
Treatment Number of foetuses Age at operation (days of gestation) Age at necropsy (days of gestation) Effect on nodules
1.0mg aIgM 1 70 140 Depleted
1.0mg aIgM 1 77 135 Depleted
1.0mg aIgM 2 84 139 Depleted
1.0mg aIgM 2 91 139, 140 Normal
1.0mg aIgM 3 98 139 Depleted
1.0mg aIgM 2 105 141 Normal
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Blood of Foetal Lambs following
Intraperitoneal Administration
To determine the persistence of mouse immunoglobulin in
the blood of foetal lambs following intraperitoneal
administration, anti-IgM antibody was administered at
around 82–85dg and serum was collected at necropsy at
times ranging from 1 to 21 days after administration (age
range at necropsy 84–105dg). Serum was also collected
at necropsy of other experimental and control foetal lambs
in the present series of experiments including additional
foetuses that received high doses of anti-IgM antibody.
Three additional foetuses were given antibody at 98dg
(12.5mg) and three at 103dg (15mg)(Table V).
Following administration of 1mg of anti-IgM antibody,
the average estimated concentration of mouse immuno-
globulin in serum was highest 3 days after administration
and was still detectable in serum 14 days after
administration. Murine immunoglobulin was not detect-
able at 21 days or at longer time intervals after
administration. With the administration of larger amounts
of antibody, high concentrations of murine immuno-
globulin were detected for longer periods after adminis-
tration, up to 45 days after administration (Table V).
DISCUSSION
This study examined the impact of an anti-IgM
monoclonal antibody, administered to foetal lambs at a
range of gestational ages and in ﬁxed and body-weight
adjusted doses, on the development of B cells in the ileal
Peyer’s patch. The intraperitoneal injection of 1mg
antibody at 63dg has been shown to result in a marked
depletion of B cells in the ileal Peyer’s patch, which
persisted until the time of necropsy just prior to birth
(Press et al., 1996). The present study showed that this
dose of antibody was effective in producing B-cell
depletion if administered at gestational ages ranging from
56 to 84dg. However, beyond 91dg, the effect appeared to
be inconsistent and was absent at 105dg. The antibody-
mediated depletion of B cells from the ileal Peyer’s patch
was restored when the dose of antibody was increased
sufﬁciently to ensure that parity with foetal body weight
was maintained. Thus, the present study shows that the
basis of anti-IgM interception of B-cell development in
the ileal Peyer’s patch of foetal lambs is the delivery of an
effective concentration of antibody, which is presumably
adequate to saturate receptors on a signiﬁcant proportion
FIGURE 3 B-cell development in the pre-natal ileal Peyer’s patch of
lambs following body weight-adjusted doses of anti-IgM antibody.
(A) Following administration of 15mg anti-IgM antibody at 105 days of
gestation (dg), small rudimentary nodules (r) are present showing
staining for CD21 (brown). (B) Following administration of 12.5mg anti-
IgM antibody at 98dg, small rudimentary nodules (r) are present that do
notshowstainingforovine IgM. (C)Followingadministration of 12.5mg
anti-IgM antibody at 98dg, small rudimentary nodules (r) are present
showing enzyme reactivity for 50nucleotidase. Bar ¼ 100mm: Frozen
sections.
TABLE III Effect of weight-adjusted dose of anti-IgM antibody (aIgM) on B-cell development
Treatment
Number
of foetuses
Age at operation
(days of gestation)
Age at necropsy
(days of gestation)
Effect on
nodules
12.5mg aIgM 1 98 137 Depleted
15.0mg aIgM 1 105 142 Depleted
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further shows that the expanding Peyer’s patch nodules
present at 105dg do not shield the proliferating B cells
from the effect of a sufﬁcient concentration of anti-IgM
antibody.
The present study did not pursue the effect of anti-IgM
antibody on the developed ileal Peyer’s patch but rather
focused on B cells that are present in the foetus up to
105dg. The ileal Peyer’s patch is responsible for
the production of the vast majority of B cells in sheep
and achieves an anatomical distribution and appearance of
the postnatal organ from about 115dg (Press et al., 1992).
Active lymphopoiesis commences in the ileal Peyer’s
patch at around 100dg (Reynolds and Morris, 1983)
but prior to this time IgMþ B cells are present in a number
of sites including the spleen (Maddox et al., 1987a),
thymus (Maddox et al., 1987b), lymph nodes
(Maddox et al., 1987c; Press et al., 1993), circulation
(Symons and Binns, 1975) and other gut-associated
lymphoid tissues (Aleksandersen et al., 1991). It should be
noted that in sheep lymphopoiesis in the bone marrow is
minor and the liver is not a source of IgMþ cells
(Miyasaka and Morris, 1988).
The spleen has been proposed as a source of
B cells that colonise the ileal Peyer’s patch in cattle
(Lucier et al., 1998) but a recent study on the effect of
early foetal splenectomy in sheep found that the spleen
was not essential for the colonisation and development of
TABLE IV Effect of splenectomy (Splx) and 1.0mg anti-IgM antibody (aIgM) administration on B-cell development. Age of foetal lambs is given as
days of gestation
Treatment Number of foetuses Age at splenectomy Age at aIgM admin. Age at necropsy Effect on nodules
aIgM only 1 – 56 142 Depleted
Splx + aIgM 1 56 56 142 Depleted
Splx + aIgM 2 56 105 138–140 Irregular sizes
Splx + aIgM 2 56 105–106 138–140 Normal
aIgM only 1 – 105 141 Normal
FIGURE 4 B-cell development in the pre-natal ileal Peyer’s patch of lambs following splenectomy at 56 days of gestation (dg) and intraperitoneal
administration of 1mg anti-IgM antibody at 105dg. Large nodules (n) showing staining for CD21 (brown) are present (A) following administration of
anti-IgM antibody at 105dg only and (B) following splenectomy at 56dg and administration of anti-IgM antibody at 105dg. In another foetus that was
splenectomised at56dgandreceived anti-IgMantibodyat105dg, dispersed nodules(n)ofirregular sizewere presentthatshowedstainingfor(C) CD21,
and (D) ovine IgM (brown). Bar ¼ 100mm: Frozen sections.
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to the colonisation of the ileal Peyer’s patch, the spleen is
a signiﬁcant site of B-cell accumulation (Press et al.,
1993) and ﬁndings in splenectomised foetuses suggest that
splenic B-cell populations inﬂuence ileal Peyer’s patch
development (Press et al., 2001). The present study found
that splenectomy at 56dg followed by administration of
1mg anti-IgM antibody at 105dg did not prevent B-cell
development in the ileal Peyer’s patch, although some
foetuses showed signs that development was affected
(Fig. 4). These experiments indicate that in the absence of
the spleen, other tissue microenvironments are able to
support and promote the expansion of B-cell populations
above the arbitrary threshold imposed by anti-IgM
administration that is necessary for the subsequent
development of the ileal Peyer’s patch. The localisation
and distribution of B cells in splenectomised foetal
sheep prior to establishment of the ileal Peyer’s patch
has not been investigated but further characterisation of
lymphocyte populations in these animals could shed light
on the relative capacity of other lymphoid tissue
microenvironments to support B-cell development
and their inﬂuence on immunoglobulin V-gene
usage and diversiﬁcation in foetal sheep (Hein and
Dudler, 1998; 1999).
An important ﬁnding in the present study was the
estimation of the concentration of mouse immunoglobulin
persisting in foetal sheep serum at various times after
intraperitoneal administration. This series of experiments
showed that high concentrations of anti-IgM antibody are
in the serum for up to two weeks after administration of a
dose of 1mg and that high concentrations are maintained
for longer periods of time if foetal weight-adjusted doses
were administered. These ﬁndings are consistent with
the low catabolic rate of ovine gamma globulin
demonstrated in foetal ruminants and suggest that
lysozymal enzymes present in the liver, spleen, lymph
nodes and plasma have a limited capacity for protein
degradation (Fukumoto and Brandon, 1985).
It is interesting to note that no murine immunoglobulin
was detectable in serum 21 days or longer after the
administration of 1mg of antibody. If, as other ﬁndings in
this study suggest, the effect of anti-IgM administration
is related to the concentration of mouse immunoglobulin
in serum, then the effect of administration of antibody
at 56dg can at most have been present until 77dg.
The investigation of B-cell depleted foetal sheep has
shown that rudimentary follicles containing follicular
dendritic cells are present in the ileum just prior to birth
(Press et al., 1998) and that B-cell populations, albeit
reduced, are present in the spleen, lymph nodes and
jejunal Peyer’s patch (Press et al., 1996). The question is
then why in the absence of anti-IgM antibody, do the
B-cell populations that are present in B-cell depleted
foetal lambs fail to colonise the emerging lymphoid
nodules of the ileal Peyer’s patch in the remaining 73 days
of gestation?
One possibility is that sufﬁcient new B cells are not
produced and/or those remaining are incapable of
colonisation. Reynaud et al. (1991) observed a limited
pattern of light chain rearrangement in the ileal Peyer’s
patch of sheep, which was interpreted to indicate that each
ileal Peyer’s patch nodule had been colonised by a small
number of precursor cells having rearranged one light
chain allele. Similar ﬁndings in the bursa of Fabricius
of the chicken have been used to argue that rearrangement
only occurs during a narrow window of development
(Reynaud et al., 1992). Thus, if on-going differentiation
of B cells from stem cells does not occur in sheep and anti-
IgM administration induces apoptosis or switches off
proliferation in existing B cells (Griebel et al., 1991;
Motyka et al., 1995), then sufﬁcient numbers of
appropriate colonising populations may not be present.
An investigation of immunoglobulin gene rearrangement
and proliferation and apoptosis in normal and B-cell
depleted foetal sheep would provide information on
whether B-cell populations emerge after anti-IgM
administration and whether B cells gain entry to the
developing nodules in anti-IgM treated foetal sheep. The
administration of anti-IgM antibody at gestational ages
earlier than 56 days should also be undertaken.
Another possible explanation for the observation of
Reynaud et al. (1991) that is also consistent with the
ﬁndings of the present study is that the ileal Peyer’s patch
can only be colonised during a limited period of gestation.
An extensive series of experiments with chick-quail
chimeras has shown that the bursa of Fabricius can only be
colonised at speciﬁc times during gestation (le Douarin
et al., 1984). Thus, anti-IgM antibody administration may
function to suppress, impede or eliminate B-cell
populations during the crucial period in which the ileal
Peyer’s patch is capable of being colonised. New B-cell
TABLE V Estimated concentration (mg/ml) of mouse immunoglobulin
in serum from foetal lambs at various times after intraperitoneal
administration of a single bolus of antibody (mg)
Number of
days after
administration
Number of
foetuses
Amount of
antibody
administered (mg)
Average estimated
concentration
(mg/ml)
1 2 1 3.4
3 2 1 5.8
4 2 1 5.5
7 2 1 4.3
14 2 1 4.1
21 2 1 0
35 1 1 0
49 2 1 0
55,58 2 1 0
70 1 1 0
86 3 1 0
40 3 12.5 7.8
45 1 12.5 8.0
37 1 15 15.8
40 2 15 13.1
44 1 15 8.0
84 (Mouse IgG) 3 1 0
Control 104dg 1 0 0
Control 125dg 1 0 0
Control 140dg 2 0 0
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may expand after anti-IgM administration buttheseBcells
are unable to gain entry to the privileged microenviron-
ment of the ileal Peyer’s patch. The presence of nodules of
irregular sizes following administration of a sub-optimal
dose (0.5 and 0.25mg) of anti-IgM antibody or in some
individuals that had been splenectomised and sub-
sequently given anti-IgM antibody may reﬂect a
disturbance of the colonisation of nodules.
The present series of experiments shows that the basis
of anti-IgM interception of B-cell development in the ileal
Peyer’s patch is the availability of adequate concentrations
of intraperitoneally administered antibody. However, the
study also shows that foetal sheep were able to clear a
1mg bolus of anti-IgM antibody within 21 days of
administration. The inability of B-cell populations to
colonise the ileal Peyer’s patch during the extended period
remaining after the clearance of a single bolus of antibody
indicates that further studies are needed to investigate the
nature of B cells that colonise Peyer’s patch nodules in
foetal sheep.
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